Convenient and cost-effective HIV care
Research helps guide the way forward
19 January 2021 | Health
The year 2020 placed heavy, unexpected financial burdens on many people, and particularly on the healthcare system. While it is critical for general healthcare services to continue, it is more important than ever to ensure that these services are as efficient and cost-effective as possible.
In order to better understand how to support patients and how to best use resources, the Ministry of Health with support from the US Centers for Disease Control and Prevention conducted two research studies. These studies were released at the end of last year. The first study assessed how well Community Adherence Groups (CAGS) support patients; the second assessed the cost of treating stable and unstable patients.
CAGs are groups of 6 to 12 HIV-positive patients who have their virus under control. The group meets on a regular basis in their community. One of the members will visit their local clinic to fetch all the medicine for the group, and the members collect their medicine when they meet. This saves the patients time and money.
The study interviewed patients and healthcare providers from three regions about community adherence groups. It found that for many patients, being part of a CAG makes it quicker and easier for patients to receive their medication. It also provides members with a safe space and a sense of community.
Healthcare workers find community adherence groups as an effective way to support patients, as when stable patients receive their main care through a CAG, healthcare providers can focus on sicker patients who recently found out that they are HIV positive.
“As a leader of the group, I look for topics that I think are interesting for the CAG members,” said one CAG member from the Oshana region. “Especially because I used to walk around in the community, I used to see the bad things that are happening. That is why I bring up topics like discrimination… They [CAG members] suggest some talks about how to do backyard gardens. With gardens, you can produce your own food like spinach and cabbages.”
Cost of care
The second study compared the cost of care for patients who have the level of the virus under control in their body (stable patients) to the cost of care for patients who do not have the level of the virus under control (unstable patients). The study also compared the cost of care for adults compared to teenagers and children living with HIV. The cost of care was based on the average cost of care over one year.
The results show that the cost of care for a stable HIV positive patient is 2-3 times lower than the cost of care for an HIV-positive patient who is not yet virally suppressed. The highest costs are for laboratory services, healthcare providers and medicine.
The study assessed the cost of patient care at nine clinics over a period of one year.
“We know that the sooner people living with HIV get treatment, the healthier they will be. The results of this study show that getting patients to regularly take their medicine also has an important impact on the cost of care, particularly by reducing the number of laboratory tests that are required,” said Dr Ndapewa Hamunime, Study Co-investigator and Senior HIV Advisor for the Ministry of Health and Social Services.
Dr Graham Mutandi, Care and Treatment Team Lead from US Centers for Disease Control and Prevention Namibia, adds: “If we help patients control the virus in their body as soon as possible, we can do less laboratory tests, reduce hospital visits and save a lot of money. Namibia has 204 000 people on treatment. Reducing the cost of HIV care and still improving the quality of patient, means that the money saved can be spent on other needs within the healthcare system.”
The Ministry of Health has made a number of recommendations from the findings of these studies. For example, the Ministry recommends that the CAG model is expanded into areas beyond HIV alone, such as livelihood, mental health, and other chronic disease care.
In order to help HIV-positive patients become stable as quickly as possible, the Ministry will continue to prioritise the roll-out of the new HIV medication, TLD, which is the most effective treatment for the majority of HIV positive patients. The Ministry will also adopt low-cost laboratory technologies as they become available. – Source CDC Namibia